Betahistine plus piracetam dual therapy versus betahistine monotherapy for peripheral vestibular vertigo: a confounder-corrected subanalysis of the OSVaLD study

References

• Oosterveld WJ. The effectiveness of piracetam in vertigo. Pharmacopsychiatry 1999;32(Suppl 1):54-60
   PubMed Web of Science ®Google Scholar
• Kuo CH, Pang L, Chang R. Vertigo – part 2 – management in general practice. Aust Fam Physician 2008;37:409-13
   PubMed Web of Science ®Google Scholar
• Lacour M. Betahistine treatment in managing vertigo and improving vestibular compensation: Clarification. J Vestib Res 2013;23:139-51
   PubMed Web of Science ®Google Scholar
• Albera R, Ciuffolotti R, Di Cicco M, et al. Double-blind, randomized, multicenter study comparing the effect of betahistine and flunarizine on the dizziness handicap in patients with recurrent vestibular vertigo. Acta Otolaryngol 2003;123:588-93
   PubMed Web of Science ®Google Scholar
• Bradoo RA, Nerurkar NK, Mhapankar JB, et al. Management of acute vertigo with betahistine. Indian J Otolaryngol Head Neck Surg 2000;52:151-8
   PubMedGoogle Scholar
• Deering RB, Prescott P, Simmons RL, Downey LJ. A double-blind crossover study comparing betahistine and cinnarizine in the treatment of recurrent vertigo in patients in general practice. Curr Med Res Opin 1986;10:209-14
   PubMed Web of Science ®Google Scholar
• Fraysse B, Bebear JP, Dubreuil C, et al. Betahistine dihydrochloride versus flunarizine. A double-blind study on recurrent vertigo with or without cochlear syndrome typical of Menière’s disease. Acta Otolaryngol Suppl 1991;490:1-10
   PubMedGoogle Scholar
• Mira E. Betahistine in the treatment of vertigo. History and clinical implications of recent pharmacological researches. Acta Otorhinolaryngol Ital 2001;21(3 Suppl 66):1-7
   PubMedGoogle Scholar
• Mira E, Guidetti G, Ghilardi L, et al. Betahistine dihydrochloride in the treatment of peripheral vestibular vertigo. Eur Arch Otorhinolaryngol 2003;260:73-7
   PubMed Web of Science ®Google Scholar
• Novotný M, Kostrica R. Fixed combination of cinnarizine and dimenhydrinate versus betahistine dimesylate in the treatment of Ménière’s disease: a randomized, double-blind, parallel group clinical study. Int Tinnitus J 2002;8:115-23
   PubMedGoogle Scholar
• Nauta JJ. Meta-analysis of clinical studies with betahistine in Ménière’s disease and vestibular vertigo. Eur Arch Otorhinolaryngol 2014;271:887-97
   PubMed Web of Science ®Google Scholar
• Benecke H, Pérez-Garrigues H, Bin Sidek D, et al; OSVaLD investigators. Effects of betahistine on patient-reported outcomes in routine practice in patients with vestibular vertigo and appraisal of tolerability: experience in the OSVaLD study. Int Tinnitus J 2010;16:14-24
   PubMedGoogle Scholar
• Pérez-Garrigues H, Kuessner D, Benecke H. Patient baseline characteristics in an open-label multinational study of betahistine in recurrent peripheral vestibular vertigo: the OSVaLD study. Curr Med Res Opin 2007;23:2753-61
   PubMed Web of Science ®Google Scholar
• Fernandes CM, Samuel J. The use of piracetam in vertigo. S Afr Med J 1985;68:806-8
   PubMed Web of Science ®Google Scholar
• Rosenhall U, Deberdt W, Frieberg U, et al. Piracetam in patients with chronic vertigo: results of a double-blind, placebo-controlled study. Clin Drug Invest 1996;11:251-60
   Web of Science ®Google Scholar
• Oosterveld WJ. The efficacy of piracetam in vertigo. A double-blind study in patients with vertigo of central origin. Arzneimittelforschung 1980;30:1947-9
   PubMed Web of Science ®Google Scholar
• Haguenauer JP. Essai clinique du piracetam dans le traitement des vertiges. Etude contrôlée versus placebo. Les Cahiers de l’Oto-Rhino-Laryngologie 1988;21:460-6
   Google Scholar
• Ozdemir H, Akinci E, Coskun F. Comparison of the effectiveness of intravenous piracetam and intravenous dimenhydrinate in the treatment of acute peripheral vertigo in the emergency department. Singapore Med J 2013;54:649-52
   PubMed Web of Science ®Google Scholar
• Malykh AG, Sadaie MR. Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders. Drugs 2010;70:287-312
   PubMed Web of Science ®Google Scholar
• Jacobson GP, Newman CW. The development of the Dizziness Handicap Inventory. Arch Otolaryngol Head Neck Surg 1990;116:424-7
   PubMed Web of Science ®Google Scholar
• Xue Z, Liu CZ, Shi GX, et al. Efficacy and safety of acupuncture for chronic dizziness: study protocol for a randomized controlled trial. Trials 2013;14:429
   PubMed Web of Science ®Google Scholar
• Whitney SL, Wrisley DM, Brown KE, Furman JM. Is perception of handicap related to functional performance in persons with vestibular dysfunction? Otol Neurotol 2004;25:139-43
   PubMed Web of Science ®Google Scholar
• Southampton Hospital. The Dizziness Handicap Inventory. 2014. Available at: https://www.southamptonhospital.org/Resources/10355/FileRepository/Forms/Dizziness%20Hanicap%20Inventory%20-%20English.pdf [Last accessed 16 January 2015]
   Google Scholar
• Nola G, Mostardini C, Salvi C, et al. Validity of Italian adaptation of the Dizziness Handicap Inventory (DHI) and evaluation of the quality of life in patients with acute dizziness. Acta Otorhinolaryngol Ital 2010;30:190
   PubMed Web of Science ®Google Scholar
• Hahn A, Novotny M, Shotekov PM, et al. Comparison of cinnarizine/dimenhydrinate fixed combination with the respective monotherapies for vertigo of various origins: a randomized, double-blind, active-controlled, multicentre study. Clin Drug Investig 2011;31:371-83
   PubMed Web of Science ®Google Scholar
• Pytel J, Nagy G, Toth A, et al. Efficacy and tolerability of a fixed low-dose combination of cinnarizine and dimenhydrinate in the treatment of vertigo: a 4-week, randomized, double-blind, active- and placebo-controlled, parallel-group, outpatient study. Clin Ther 2007;29:84-98
   PubMed Web of Science ®Google Scholar
• Scholtz AW, Schwarz M, Baumann W, et al. Treatment of vertigo due to acute unilateral vestibular loss with a fixed combination of cinnarizine and dimenhydrinate: a double-blind, randomized, parallel-group clinical study. Clin Ther 2004;26:866-77
   PubMed Web of Science ®Google Scholar
• Deng Y, Zhu HQ, Deng GB, Tan C. [A clinical study on the effect of Yinxing Damo combined with betahistine hydrochloride injection on vertebral basilar artery ischemic vertigo]. Chin J Integr Med 2005;11:229-31
   PubMedGoogle Scholar
• Guneri EA, Kustutan O. The effects of betahistine in addition to Epley maneuver in posterior canal benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg 2012;146:104-8
   PubMed Web of Science ®Google Scholar
• Ordosgoitia H, Castro C, Carbayeda M, Labella T. [Clinical trial of the use of the combination of piracetam and dihydroergocristine in vertigo from different causes]. An Otorrinolaringol Ibero Am 1989;16:271-9
   PubMedGoogle Scholar